Screening of the adult population in Iran for coeliac disease: Comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 11, 2006, Pages 1181-1186

  Reza Akbari, Mohammad ^a   Mohammadkhani, Ashraf ^a   Fakheri, Hafez ^b   Javad Zahedi, Mohammad ^c   Shahbazkhani, Bijan ^a   Nouraie, Mehdi ^a   Sotoudeh, Masoud ^a   Shakeri, Ramin ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti endomysial antibody; Anti tissue transglutaminase antibody; Coeliac disease; Iran

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; INTESTINE BIOPSY; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIBODIES; AUTOANTIBODIES; CELIAC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; IRAN; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES; TRITICUM;

EID: 33749818892     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000224477.51428.32     Document Type: Article

References (48)

1. Marsh MN. The natural history of gluten sensitivity: defining, refining and redefining. QJ Med 1995; 88:9-13.
2. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120:636-651.
3. Martucci S, Biagi P, Di Sabatino A, Corazza GR. Coeliac disease. Dig Liver Dis 2002; 34 (suppl 2):150-153.
4. Trier JS. Celiac sprue. N Engl J Med 1991; 325:709-719.
5. Goggins M, Kelleher D. Celiac disease and other nutrient related injuries to the gastrointestinal tract. Am J Gastroenterol 1994; 89 (suppl 8):S2-S17.
6. Ferguson A. New perspectives of the pathogenesis of celiac disease: evolution of a working clinical definition. J Int Med 1996; 240:315-318.
7. Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis 2004; 36:492-498.
8. Biagi F, Corazza GR. Clinical features of coeliac disease. Dig Liver Dis 2002; 34:229-237.
9. Chorzelski TP, Beutner EH, Sulej J, Tchorzewska H, Jablonska S, Kumar V, Kapuscinska A. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984; 111:395-402.
10. Abdulkarim AS, Murray JA. Review article: the diagnosis of coeliac disease. Aliment Pharmacol Ther 2003; 17:987-995.
11. Farrell RJ, Kelly CP. Diagnosis of celiac sprue. Am J Gastroenterol 2001; 96:3237-3246.
12. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999; 94:888-894.
13. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature 1997; 3:797-801.
14. Greenberg CS, Birkbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991; 5:3071-3077.
15. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115:1317-1321.
16. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115:1322-1328.
17. Hansson T, Dahlbom I, Hall J, Holtz A, Elfman L, Dannaeus A, Klareskog L. Antibody reactivity against human and guinea pig tissue transglutaminase in children with coeliac disease. J Pediatr Gastroenterol Nutr 2000; 30:379-384.
18. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45:2142-2149.
19. Scoglio R, Pasquale GD, Pagano G, Lucanto MC, Magazzu G, Sferlazzas C. Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol 2003; 98:1325-1331.
20. Shahbazkhani B, Malekzadeh R, Sotoudeh M, Moghadam KF, Farhadi M, Ansari R, et al. High prevalence of celiac disease in apparently healthy blood donors. Eur J Gastroenterol Hepatol 2003; 15:475-478.
21. McMillan SA. Simple method for detecting IgA deficient patients with celiac disease: preliminary results. In: 11th International Symposium on Coeliac Disease. Belfast, Northern Ireland, 28-30 April 2004.
22. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992; 102:330-354.
23. Rostami K, Keckhaert J, Van der Ven F, Meijer JW,Wahab P, Mulder CJ, et al. SAT compared to serology in adult coeliacs: seronegative coeliac disease seems a reality. Neth J Med 1998; 53:15-19.
24. Walter SD. Estimation of test sensitivity and specificity when disease confirmation is limited to positive results. Epidemiology 1999; 10:67-72.
25. Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis of 1026 consecutive cases. Am J Gastroenterol 1999; 94:691-696.
26. Unsworth DJ, Lock RJ, Harvey RF. Improving the diagnosis of coeliac disease in anaemic women. Br J Haematol 2000; 111:898-901.
27. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at risk and not-at-risk groups in the United States. Arch Intern Med 2003; 163:286-292.
28. Ascher H, Hahn-Zoric M, Hanson LÅ, Kilander AF, Nilsson LA, Tlaskalova H. Value of serologic markers in clinical diagnosis and population studies of celiac disease. Scand J Gastroenterol 1996; 31:61-67.
29. Catassi C, Fanciulli G, D'Appello AR, El Asmar R, Rondina C, Fabiani E, et al. Antiendomysium versus antigliadin antibodies in screening the general population for celiac disease. Scand J Gastroenterol 2000; 35:732-736.
30. Riestra S, Fernandez E, Rodrigo L, Garcia S, Ocio G. Prevalence of celiac disease in the general population of northern Spain. Strategies of serologic screening. Scand J Gastroenterol 2000; 35:398-402.
31. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000; 35:181-183.
32. Shamir R, Lerner A, Shinar E, Lahat N, Sobel E, Bar-or R, et al. The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol 2002; 97:2589-2594.
33. Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, et al. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 2002; 48:1546-1550.
34. Martini S, Mengozzi G, Aimo G, Giorda L, Pagni R, Guidetti CS. Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up. Clin Chem 2002; 48:960-963.
35. Fabiani E, Catassi C, and the International Working Group on Eu-tTG. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of celiac disease. Results of an international multi-center study. Eur J Gastroenterol Hepatol 2001; 13:659-665.
36. Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage. I. Celiac disease. J Clin Gastroenterol 2003; 36:219-221.
37. Shahbazkhani B, Mohammadnejad M, Malekzadeh R, Akbari MR, Esfahani MM, Nasserimoghadam S, et al. Coeliac disease is the most common cause of chronic diarrhoea in Iran. Eur J Gastroenterol Hepatol 2004; 16:665-668.
38. Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, Malekzadeh R. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18:231-235.
39. Bahari A, Aarabi M, Hedayati M, Samie S, Aghazadeh R, Zali MR. Seroprevalence of coelic disease among patients with inflammatory bowel disease [Abstract]. Govaresh 2003; 7:238.
40. Sima H, Hekmatdoost A, Ghaziani T. Seroprevalence of coelic disease among autoimmune and HBV chronic hepatitis in Tehran Iran [Abstract]. Govaresh 2003; 7:237.
41. Shahbazkhani B, Akbari MR, Nafisi S, Sotoudeh M, Malekzadeh R. Coeliac disease and epilepsy [Abstract]. Gut 2004; 53 (suppl VI):A195.
42. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in celiac disease - effect of gluten-free diet. Gut 1989; 30:333-338.
43. Ferguson A, Kingstone K. Coeliac disease and malignancies. Acta Paediatr 1996; 412 (suppl):78-81.
44. Gobbi G, Bouquet F, Greco L, Lambertini A, Tassinari CA, Ventura A, Zaniboni MG. Coeliac disease, epilepsy, and cerebral calcifications. Lancet 1992; 340:439-443.
45. Hadjivassiliou M, Gibson A, Davies-Jones GAB, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996; 347:369-371.
46. Hallert C, Derefeldt T. Psychic disturbances in adult celiac disease. I. Clinical observations. Scand J Gastroenterol 1982; 17:17-19.
47. Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Acta Paediatr 1996; 412 (suppl):76-77.
48. Corazza GR, Di Sario A, Cecchetti L, Tarozzi C, Corrao G, Bernardi M, Gasbarrini G. Bone mass and metabolism in patients with coeliac disease. Gastroenterology 1995; 109:122-128.